Cold-cough

Commercial

Portfolio-7447-for-WEB

NCE Pipeline

Discovery-7447-for-WEB

Research

Latest Annual Report

Vernalis-AR2013-CoverApr 01, 2014

2013 Results Download our latest report...        


Archive

Latest Webcast

ceoApril 01, 2014

Our latest webcast is available to view here...


Archive

Share Price

Share price:  48.76p
Change:  -0.24 (-0.49%)
As at:  30 October 2014 18:15:01
Volume:  0
LSE ID:  VER

Share price details

Latest News

CTI BioPharma Corp. becomes Vernalis’ worldwide licensee for tosedostat

Vernalis plc today announces that CTI BioPharma Corp. (CTI), a US corporation publicly listed on NASDAQ, replaces the UK venture capital backed Chroma Therapeutics (Chroma) as worldwide licensee of tosedostat.

Read more...

Contact Vernalis

T: 0118 938 0000
F: 0118 938 0001

Contact information
Maps and directions
Contact form